Fidelity Disruptive Medicine ETF (FMED) Institutional Ownership → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free FMED Stock Alerts $24.48 +0.23 (+0.95%) (As of 05/9/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartHoldingsOwnershipRatingsSocial MediaStock AnalysisChartHoldingsOwnershipRatingsSocial Media Institutional Ownership Changes (13F Filings) for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$748.73KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$435.91K Get FMED Insider Trade Alerts Want to know when executives and insiders are buying or selling Fidelity Disruptive Medicine ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Fidelity Disruptive Medicine ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/16/2024 Wealth Enhancement Advisory Services LLC496,857$12.68M0.0%+6.3%23.437% 11/13/2023FMR LLC737,997$16.33M0.0%-2.6%34.811% (Data available from 1/1/2016 forward) FMED Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FMED shares? During the previous two years, the following institutional investors and hedge funds held shares of Fidelity Disruptive Medicine ETF shares: FMR LLC ($16.33M), Wealth Enhancement Advisory Services LLC ($12.68M).Learn more on FMED's institutional investors. Which institutional investors have been buying Fidelity Disruptive Medicine ETF stock? The following institutional investors have purchased Fidelity Disruptive Medicine ETF stock in the last 24 months: Wealth Enhancement Advisory Services LLC ($29.34K). How much institutional buying is happening at Fidelity Disruptive Medicine ETF? Institutional investors have bought a total of 29,339 shares in the last 24 months. This purchase volume represents approximately $748.73K in transactions. Which Fidelity Disruptive Medicine ETF major shareholders have been selling company stock? The following institutional investors have sold Fidelity Disruptive Medicine ETF stock in the last 24 months: FMR LLC ($19.70K). How much institutional selling is happening at Fidelity Disruptive Medicine ETF? Institutional investors have sold a total of 19,697 shares in the last 24 months. This volume of shares sold represents approximately $435.91K in transactions. Related Companies: FBOT Institutional Ownership FDCF Institutional Ownership FDFF Institutional Ownership FDTX Institutional Ownership FDIF Institutional Ownership ARVR Institutional Ownership NZUS Institutional Ownership EKG Institutional Ownership WNDY Institutional Ownership UCYB Institutional Ownership This page (NASDAQ:FMED) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.